Get startedLog in
    Picture of Cidara Therapeutics logo

    CDTX — Cidara Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Brief: Cidara Therapeutics Announces Approval Of Rezzayo By The MHRA For Treatment Of Invasive Candidiasis In Adults

    Picture of Cidara Therapeutics logoCidara Therapeutics
    29/01/2024 22:10
    Jan 29 (Reuters) - Cidara Therapeutics Inc  CDTX.O :
    * CIDARA THERAPEUTICS ANNOUNCES APPROVAL OF REZZAYO BY THE
MHRA
FOR THE TREATMENT OF INVASIVE CANDIDIASIS IN ADULTS
    * CIDARA THERAPEUTICS INC: ENTITLED TO RECEIVE A MILESTONE
PAYMENT
OF APPROXIMATELY $2.8 MILLION FROM MUNDIPHARMA

Source text for Eikon:  ID:nGNX65tmRC 
Further company coverage:  CDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cidara Therapeutics

    See all news